Lebel, E.; Kastritis, E.; Palladini, G.; Milani, P.; Theodorakakou, F.; Aumann, S.; Lavi, N.; Shargian, L.; Magen, H.; Cohen, Y.;
et al. Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study. Cancers 2023, 15, 1710.
https://doi.org/10.3390/cancers15061710
AMA Style
Lebel E, Kastritis E, Palladini G, Milani P, Theodorakakou F, Aumann S, Lavi N, Shargian L, Magen H, Cohen Y,
et al. Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study. Cancers. 2023; 15(6):1710.
https://doi.org/10.3390/cancers15061710
Chicago/Turabian Style
Lebel, Eyal, Efstathios Kastritis, Giovanni Palladini, Paolo Milani, Foteini Theodorakakou, Shlomzion Aumann, Noa Lavi, Liat Shargian, Hila Magen, Yael Cohen,
and et al. 2023. "Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study" Cancers 15, no. 6: 1710.
https://doi.org/10.3390/cancers15061710
APA Style
Lebel, E., Kastritis, E., Palladini, G., Milani, P., Theodorakakou, F., Aumann, S., Lavi, N., Shargian, L., Magen, H., Cohen, Y., Gatt, M. E., & Vaxman, I.
(2023). Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study. Cancers, 15(6), 1710.
https://doi.org/10.3390/cancers15061710
